Anti-JAK-1 monoclonal antibody

Pre-made anti-JAK-1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to JAK-1/JAK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T62460-Ab-1/ GM-Tg-hg-T62460-Ab-2Anti-Human JAK-1/JAK1 monoclonal antibodyHuman
GM-Tg-rg-T62460-Ab-1/ GM-Tg-rg-T62460-Ab-2Anti-Rat JAK-1/JAK1 monoclonal antibodyRat
GM-Tg-mg-T62460-Ab-1/ GM-Tg-mg-T62460-Ab-2Anti-Mouse JAK-1/JAK1 monoclonal antibodyMouse
GM-Tg-cynog-T62460-Ab-1/ GM-Tg-cynog-T62460-Ab-2Anti-Cynomolgus/ Rhesus macaque JAK-1/JAK1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T62460-Ab-1/ GM-Tg-felg-T62460-Ab-2Anti-Feline JAK-1/JAK1 monoclonal antibodyFeline
GM-Tg-cang-T62460-Ab-1/ GM-Tg-cang-T62460-Ab-2Anti-Canine JAK-1/JAK1 monoclonal antibodyCanine
GM-Tg-bovg-T62460-Ab-1/ GM-Tg-bovg-T62460-Ab-2Anti-Bovine JAK-1/JAK1 monoclonal antibodyBovine
GM-Tg-equg-T62460-Ab-1/ GM-Tg-equg-T62460-Ab-2Anti-Equine JAK-1/JAK1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T62460-Ab-1/ GM-Tg-hg-T62460-Ab-2; GM-Tg-rg-T62460-Ab-1/ GM-Tg-rg-T62460-Ab-2;
GM-Tg-mg-T62460-Ab-1/ GM-Tg-mg-T62460-Ab-2; GM-Tg-cynog-T62460-Ab-1/ GM-Tg-cynog-T62460-Ab-2;
GM-Tg-felg-T62460-Ab-1/ GM-Tg-felg-T62460-Ab-2; GM-Tg-cang-T62460-Ab-1/ GM-Tg-cang-T62460-Ab-2;
GM-Tg-bovg-T62460-Ab-1/ GM-Tg-bovg-T62460-Ab-2; GM-Tg-equg-T62460-Ab-1/ GM-Tg-equg-T62460-Ab-2
Products NameAnti-JAK-1/JAK1 monoclonal antibody
Formatmab
Target NameJAK-1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-JAK-1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T62460-Ag-1Recombinant multi-species JAK1/ JAK-1/ JAK1AB protein


    Target information

    Target IDGM-T62460
    Target NameJAK-1
    Gene ID3716,16451,84598,677689,442952,101084377,537201,100054008
    Gene Symbol and SynonymsAIIDE,BAP004,C130039L05Rik,JAK-1,JAK1,JAK1A,JAK1B,JTK3
    Uniprot AccessionP23458
    Uniprot Entry NameJAK1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000162434
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: JAK-1, gene name: JAK1, also named as JAK1AB, JTK3, JAK1. This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.